Cowen analyst Steven Mah reiterated an Outperform rating on Twist Bioscience (NASDAQ: TWST) on a new DNA supply agreement with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE